Increasing age (per decade) |
0.34 (0.30-0.38) |
<.001 |
Female sex (vs male sex) |
0.89 (0.67-1.18) |
.4 |
Race (vs White) |
|
|
Black |
1.06 (0.42-2.66) |
.9 |
Other |
0.77 (0.36-1.61) |
.5 |
Insured (vs uninsured) |
2.83 (1.49-5.37) |
.001 |
Charlson Comorbidity Index (vs 0) |
|
|
1 |
1.04 (0.82-1.30) |
.8 |
2+ |
0.95 (0.68-1.32) |
.8 |
Education above median (vs below median) |
1.04 (0.83-1.31) |
.72 |
Income above median (vs below median) |
1.32 (1.05-1.66) |
.017 |
Mid-esophageal tumor location (vs distal) |
0.83 (0.55-1.26) |
.4 |
Clinical T stage (vs T1) |
|
|
T2 |
1.37 (0.74-2.53) |
.3 |
T3 |
1.70 (0.96-3.01) |
.07 |
Clinical N-positive disease (vs cN0) |
1.18 (0.96-1.46) |
.112 |
Distance from treatment facility (per 50 miles) |
1.42 (1.22-1.65) |
<.001 |
Treatment facility type (vs community) |
|
|
Integrated network program |
1.54 (1.19-2.00) |
.001 |
Research/academic program |
1.77 (1.42-2.2) |
<.001 |